Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.65K Buy
+55
New +$2.81K ﹤0.01% 390
2022
Q3
– Sell
-6,615
Closed -$360K – 243
2022
Q2
$360K Buy
+6,615
New +$365K 0.13% 74

Other funds holding GSK

Canton Hathaway's GSK Position: Q3 2026 in Review

Canton Hathaway opened a new position in GSK (GSK) in Q3 2026: 55 shares worth $2.65K. The stake represents ﹤0.01% of the portfolio and ranks #390 among its holdings. This is a return to the name: Canton Hathaway previously reported a position in GSK as recently as Q2 2022.

Canton Hathaway first reported a position in GSK in Q2 2022 and has held it in 2 quarters since. The position peaked at $360K in Q2 2022. 992 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Canton Hathaway held 55 shares of GSK worth $2.65K as of Q3 2026.
  • GSK was a new Canton Hathaway position in Q3 2026.
  • GSK made up ﹤0.01% of Canton Hathaway's portfolio in Q3 2026, its #390 holding.
  • Canton Hathaway first reported a position in GSK in Q2 2022 and has held it in 2 quarters since.
  • Canton Hathaway's GSK position peaked at $360K in Q2 2022.
  • 992 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Canton Hathaway's 13F filing for Q3 2026, filed 23 Oct 2026.